Avidity Biosciences, Inc.
Compositions and methods of treating muscle atrophy and myotonic dystrophy

Last updated:

Abstract:

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.

Status:
Grant
Type:

Utility

Filling date:

17 Sep 2020

Issue date:

22 Feb 2022